comparemela.com
9
10
11
12
13
14
15
Latest Breaking News On - Diabetes drugs - Page 8 : comparemela.com
Embecta Shares Fall Despite Outlook Raise, Strong 1Q
By Dean Seal Shares of Embecta fell despite the company raising its full-year outlook and recording better-than-expected results in its fiscal first quarter..
Dean-seal
Article-normal
Pharmaceuticals
Healthcare-life-sciences
Specialized-drugs-medications
Hormone-products
Diabetes-drugs
Financial-performance
Share-price-movement-disruptions
Corporate-industrial-news
Equity-markets
Eli Lilly's stock surges toward a 5th straight record after an earnings beat and upbeat outlook
U.S. prices for Lilly’s drugs climbed 27%, driven by diabetes treatment Mounjaro, while prices outside the U.S. fell.
Eli-lilly
Article-normal
Weightloss
Diabetes
Pharmaceuticals
Machinery
Agricultural-machinery
Health-care
Specialized-drugs-medications
Hormone-products
Industrial-goods
Pharma companies raise prices on over 900 drugs amid 'historic' negotiations
Drug companies raised prices on 910 name-brand drugs in January. The median price increase was 4.7%, the lowest increase in over a decade.
Italy
United-states
American
America
Americans
Italian
Antonio-ciaccia
Xavier-becerra
Hill-dermaceuticals
Leigh-purvis
Eli-lilly-mounjaro
Eli-lilly-co
NC State Health Plan is ending coverage of weight-loss drugs. What members need to know
Here are answers to frequently asked questions about changes to the NC State Health Plan’s coverage of weight-loss drugs like Wegovy and Saxenda.
Michigan
United-states
Connecticut
Novo-nordisk
Nicole-ferreira
Frank-lester
University-of-michigan
Health-plan
University-of-texas
Nc-state-health-plan
State-health-plan
Deputy-treasurer-frank
China Diabetes Care Drugs Market to Reach USD 13.73 Billion
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) The
Dublin
Ireland
China
Chinese
Novo-nordisk
Eli-lilly
Novartis
Astrazeneca
Sanofi-aventis
Boehringer-ingelheim
Bristol-myers-squibb
Pfizer
vimarsana © 2020. All Rights Reserved.